期刊文献+

HIV-2gp105-gag截短体在毕赤酵母中重组表达研究 被引量:2

Expression of HIV-2 gp105-gag truncated gene in Pichia pastoris
原文传递
导出
摘要 目的 实现HIV 2 RODgp10 5 gag截短体重组蛋白tgp10 5 gag的高效分泌表达 ,对其表达条件进行研究。方法 用PCR方法获得HIV 2 RODtgp10 5截短基因 ,将其与HIV 2 RODgag构建HIV 2 RODtgp10 5 gag嵌合基因并克隆到毕赤酵母 (Pichiapastoris)分泌型表达载体pPIC9中 ,转化GS115酵母菌 ,经MD/MM表型筛选、PCR扩增筛选阳性克隆 ,以甲醇诱导表达后进行SDS PAGE分析及Westernblot证实。结果 HIV 2 RODtgp10 5 gag嵌合截短基因在Pichiapastoris酵母系统中获得了有效分泌表达 ,相对分子质量 (Mr)约为 14 0× 10 3 ,表达量约为 16 % ,表达产物可被HIV 2阳性血清识别。最佳表达条件是大于 85 %的溶解氧 ,摇瓶转速 2 4 0r/min ,1.0 %~ 1.5 %甲醇诱导 ,培养时间 3d。结论 在Pichiapas toris表达系统中实现了HIV 2 RODtgp10 5 gag蛋白的有效分泌性表达 ,表达产物具有良好的抗原特异性。 Objective To carry out the secretive express of HIV 2 ROD tgp105 gag protein and the optimization of expression conditions. Methods HIV 2 gp105 truncated gen (tgp105) was obtained by PCR amplification and was cloned into a secreting expression vector pPIC 9. Recombinant expression vector pPIC9 tgp105 gag was constructed by inserting HIV 2 gag into pPIC9 tgp105 recombinant plasmid, then transformed into GS115 cells. Positive clones were selected with MD/MM plates and confirmed by PCR. Several clones were incubated in BMGY media and induced by 0.5% methanol in BMMY media. The expression product HIV 2 tgp105 gag protein was analyzed by SDS PAGE and confirmed by Western blot. Results The tgp105 gag protein was secreted into media. The molecular weight of the expressed protein, as analyzed by SDS PAGE, was 140kD. The Western blot result showed that the expressed protein could be detected by HIV 2 specific antibody. Conclusion The recombinant plasmid HIV 2 ROD tgp105 gag was successfully expressed in Pichia pastoris and the expressed protein has a good antigen specificity. [
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2003年第5期371-374,共4页 Chinese Journal of Microbiology and Immunology
基金 国家"8 63"高技术计划项目 (No .2 0 0 1AA2 15 0 3 1 3 ) 国家杰出青年基金资助项目 (No.3 982 5 119)
关键词 HIV-2 人免疫缺陷病毒 gpl05-gag 毕赤酵母 基因表达 HIV 2 gp105 gag Pichia pastoris Expression of foreign gene
  • 相关文献

参考文献8

  • 1Sambrook J Fritsch EF著.金冬雁 黎盂枫译.分子克隆实验指南:第二版[M].北京:科学出版社,1992.. 被引量:4
  • 2Bolognesi D. Progress in vaccine development against SlY and HIV. JAIDS, 1990, 3: 390-394. 被引量:1
  • 3Reeves JD, Robert W. Doms human immunodeficiency virus type 2. J Gen Virol, 2002, 83: 1253-1265. 被引量:1
  • 4Kang CY, Luo L, Wainberg MA, et al. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Biol-Chem, 1999, 380(3) : 353-364. 被引量:1
  • 5Nabel GJ. Challenges and opportunities for development of an AIDS vaccine. Nature, 2001, 410(6831) : 1002-1007. 被引量:1
  • 6McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV.Nature, 2001, 410(6831): 980-987. 被引量:1
  • 7Goulder PJ, Rowland-Jones SL, McMichael AJ, et al. Anti-HIV cellular immunity: recent advances towards vaccine design. AIDS, 1999,13(Suppl A) : S121-136. 被引量:1
  • 8Sattentau Q J, Meulard M, Brivet B, et al. Antibody neutralization of HIV-1 and the potential for vaccine design. Immunol Letter, 1999,66(1-3) : 143-149. 被引量:1

共引文献3

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部